Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 84.60
+2.55 (3.11%)
Feb 26, 2026, 5:35 PM CET
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €4.2 billion as of February 26, 2026. Its market cap has increased by 49.59% in one year.
Market Cap
4.20B
Enterprise Value
4.28B
Revenue
724.20M
Ranking
n/a
PE Ratio
34.64
Stock Price
€84.60
Market Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 147.07M to 4.20B, an increase of 2,753.71%. That is a compound annual growth rate of 20.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 4.20B | 29.21% |
| Dec 31, 2025 | 3.25B | 0.87% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.62B |
| Almirall | 2.76B |
| Faes Farma | 1.56B |
| Pharma Mar | 1.38B |
| Clínica Baviera | 842.24M |
| Oryzon Genomics | 246.42M |
| Atrys Health | 231.42M |
| Prim, S.A. | 218.66M |